ARRJ.F Stock Overview
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Arjo AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr4.59 |
| 52 Week High | kr4.85 |
| 52 Week Low | kr3.70 |
| Beta | 0.29 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 14.75% |
| 3 Year Change | n/a |
| 5 Year Change | 31.14% |
| Change since IPO | 45.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| ARRJ.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | 14.8% | -3.7% | 19.3% |
Return vs Industry: ARRJ.F exceeded the US Medical Equipment industry which returned -3.7% over the past year.
Return vs Market: ARRJ.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| ARRJ.F volatility | |
|---|---|
| ARRJ.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ARRJ.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ARRJ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 6,667 | Joacim Lindoff | www.arjo.com/int/ |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
| ARRJ.F fundamental statistics | |
|---|---|
| Market cap | US$1.20b |
| Earnings (TTM) | US$44.07m |
| Revenue (TTM) | US$1.01b |
27.3x
P/E Ratio1.2x
P/S RatioIs ARRJ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARRJ.F income statement (TTM) | |
|---|---|
| Revenue | kr10.98b |
| Cost of Revenue | kr6.24b |
| Gross Profit | kr4.74b |
| Other Expenses | kr4.26b |
| Earnings | kr480.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 12, 2024
| Earnings per share (EPS) | 1.76 |
| Gross Margin | 43.13% |
| Net Profit Margin | 4.37% |
| Debt/Equity Ratio | 57.5% |
How did ARRJ.F perform over the long term?
See historical performance and comparison